Nasofan, Nasenspray

7680581690048 CH-58169 Nasenspray

Associated product:

NASOFAN spray nasal 50 mcg 120 dos
Nasofan, Nasenspray
Nasofan, Nasenspray
Nasofan, Nasenspray
1 / 3
google

Article details

Package size
120
Selling units
120
Measure
Inhalationen
Galenic form
Nasenspray
Galenic group
Nasenmittel

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
01/08/2025
Patient information leaflet
Français
01/08/2025
Patient information leaflet
Italien
01/08/2025
Summary of Product Characteristics
Allemand
01/08/2025
Summary of Product Characteristics
Français
01/08/2025
Summary of Product Characteristics
Italien
01/08/2025

Detailed composition

Substance Quantity Type Category
(N/A)
50.0 UG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Konservierungsstoff (Conservateur)
(N/A)
40.0 UG Substance Konservierungsstoff (Conservateur)
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 31.25
Specialties list
Yes
Generic
Yes
SL addition date: 01/03/2009

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
58169
Drug name
Nasofan, Nasenspray, Suspension
Galenic form
NASS
ATC Code
R01AD08
Authorization status
Z
Dispensing category
B
First authorization
02/02/2009
Authorization expiration date
31/12/9999
IT Number
12.02.3.
Domain
Human medicine
Field of application
Saisonale Rhinitis und perenniale Rhinitis

Package details

Description (FR)
NASOFAN spray nasal 50 mcg 120 dos
Description (DE)
NASOFAN Nasenspray 50 mcg 120 Dos
Market launch
02/02/2009
Narcotic (BTM)
No

Other package sizes (2)

None
60 INH
GTIN: None
Not in V1
None
150 INH
GTIN: None
Not in V1